These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16103763)

  • 1. Cost effectiveness and delivery study for future HIV vaccines.
    Barth-Jones DC; Cheng H; Kang LY; Kenya PR; Odera D; Mosqueira NR; Mendoza W; Portela MC; Brito C; Tangcharoensathien V; Akaleephan C; Supantamart S; Patcharanarumol W; de Macedo Brigido LF; Fonseca MG; Sanchez M; Chang ML; Osmanov S; Avrett S; Esparza J; Griffiths U;
    AIDS; 2005 Sep; 19(13):w1-6. PubMed ID: 16103763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low- and Middle-Income Countries.
    Harmon TM; Fisher KA; McGlynn MG; Stover J; Warren MJ; Teng Y; Näveke A
    PLoS One; 2016; 11(1):e0146387. PubMed ID: 26731116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand.
    Leelahavarong P; Teerawattananon Y; Werayingyong P; Akaleephan C; Premsri N; Namwat C; Peerapatanapokin W; Tangcharoensathien V
    BMC Public Health; 2011 Jul; 11():534. PubMed ID: 21729309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public health considerations for the use of a first generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20-21 November 2002.
    Chang ML; Vitek C; Esparza J;
    AIDS; 2003 Oct; 17(15):W1-10. PubMed ID: 14523295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model.
    Hontelez JA; Nagelkerke N; Bärnighausen T; Bakker R; Tanser F; Newell ML; Lurie MN; Baltussen R; de Vlas SJ
    Vaccine; 2011 Aug; 29(36):6100-6. PubMed ID: 21703321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future access to HIV vaccines. Report from a WHO-UNAIDS Consultation, Geneva, 2-3 October 2000.
    AIDS; 2001 May; 15(7):W27-44. PubMed ID: 11399975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economics of HIV vaccines: projecting the impact of HIV vaccination of infants in sub-Saharan Africa.
    Bos JM; Postma MJ
    Pharmacoeconomics; 2001; 19(9):937-46. PubMed ID: 11700780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential impact of an HIV vaccine with limited protection on HIV incidence in Thailand: a modeling study.
    Nagelkerke NJ; Hontelez JA; de Vlas SJ
    Vaccine; 2011 Aug; 29(36):6079-85. PubMed ID: 21718745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the demand for a preventive HIV vaccine: why we need to do better. Reliable estimates would help in achieving several policy and advocacy objectives.
    Hecht R; Suraratdecha C
    PLoS Med; 2006 Sep; 3(10):e398. PubMed ID: 16953657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa.
    Selinger C; Bershteyn A; Dimitrov DT; Adamson BJS; Revill P; Hallett TB; Phillips AN; Bekker LG; Rees H; Gray G
    Vaccine; 2019 Apr; 37(16):2258-2267. PubMed ID: 30890385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential demand for an AIDS vaccine in Thailand.
    Tangcharoensathien V; Phoolcharoen W; Pitayarangsarit S; Kongsin S; Kasemsup V; Tantivess S; Suraratdecha C
    Health Policy; 2001 Aug; 57(2):111-39. PubMed ID: 11395178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study.
    de Montigny S; Adamson BJS; Mâsse BR; Garrison LP; Kublin JG; Gilbert PB; Dimitrov DT
    Sci Rep; 2018 Apr; 8(1):6066. PubMed ID: 29666455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS vaccine research in Asia: needs and opportunities. Report from a UNAIDS/WHO/NIID meeting Tokyo, 28-30 October 1998.
    AIDS; 1999 Jul; 13(11):UNAIDS 1-UNAIDS 13. PubMed ID: 10449273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The private demand for an AIDS vaccine in Thailand.
    Suraratdecha C; Ainsworth M; Tangcharoensathien V; Whittington D
    Health Policy; 2005 Mar; 71(3):271-87. PubMed ID: 15694496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Case for Adolescent HIV Vaccination in South Africa: A Cost-Effectiveness Analysis.
    Moodley N; Gray G; Bertram M
    Medicine (Baltimore); 2016 Jan; 95(4):e2528. PubMed ID: 26825890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and Thailand.
    Andersson KM; Stover J
    Vaccine; 2011 Aug; 29(36):6092-9. PubMed ID: 21703322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demand forecasting for preventive AIDS vaccines: economic and policy dimensions.
    Hecht R; Gandhi G
    Pharmacoeconomics; 2008; 26(8):679-97. PubMed ID: 18620461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa.
    Amirfar S; Hollenberg JP; Abdool Karim SS
    J Acquir Immune Defic Syndr; 2006 Oct; 43(2):219-25. PubMed ID: 16951648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Household demand for preventive HIV/AIDS vaccines in Thailand: do husbands' and wives' preferences differ?
    Whittington D; Suraratdecha C; Poulos C; Ainsworth M; Prabhu V; Tangcharoensathien V
    Value Health; 2008; 11(5):965-74. PubMed ID: 18194396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.